Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

1:05 PM - 1:15 PM PT

314 - Osteoradionecrosis as a Complication Following Intensity-Modulated Radiation Therapy or Proton Therapy in the Treatment of Oropharyngeal Carcinoma
Speaker: Dee, Edward, MD - Memorial Sloan Kettering Cancer Center, Middletown Township, NJ
1:05 PM - 1:15 PM PT

319 - Cholesterol Flux Rewiring through LDLR Palmitoylation Establishes a Mitochondrial Shield and Immune Desert in Radioresistant Tumors
Speaker: Zhong, Weidong - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
1:05 PM - 1:15 PM PT

324 - First Analytic Dose Calculation Algorithm for Proton Minibeam Radiotherapy
Speaker: Li, Wangyao, PhD - University of Kansas Medical Center, Kansas City, KS
1:10 PM - 1:15 PM PT

1058 - Reproducibility of Statistically Significant Phase III Oncology Trials: An In Silico<em> </em>Meta-Epidemiological Analysis
Speaker: Sherry, Alexander, MD - University of Texas MD Anderson Cancer Center, Houston, TX
1:15 PM - 1:20 PM PT

1059 - Multitask Double Machine Learning for Counterfactual Estimation of Survival and Toxicity in Locally Advanced Non-Small Cell Lung Cancer Chemoradiotherapy
Speaker: Lee, Sang Ho, PhD - University of Pennsylvania, Philadelphia, PA
1:15 PM - 1:25 PM PT

303 - Impact of Castrate Sensitivity and Genetic Mutations on Local Control after Spine Stereotactic Body Radiation Therapy for Prostate Cancer Spinal Metastases
Speaker: Jackson, Christopher, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY
1:15 PM - 1:25 PM PT

309 - Efficacy and Safety of Camrelizumab and Apatinib in Combination with IMRT in Unresectable Hepatocellular Carcinoma: A Non-Randomised Phase 2 Study
Speaker: Wang, Hong-zhi, MD, MS - Cancer Hospital, Chinese Academy of Medical Science, Peking Union Medical College, BeiJing, Beijing
1:15 PM - 1:25 PM PT

315 - Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A Phase 1 Dose-Escalation Trial of Patients with Xerostomia after Radiation Therapy for Head and Neck Cancer
Speaker: Blitzer, Grace, MD - University of Wisconsin Madison, Madison, WI
1:15 PM - 1:25 PM PT

320 - Hypoxanthine Enforces Cytotoxic CD8<sup>+</sup> T Cells via Purine Salvage Synthesis and Epigenetic Modification to Potentiate Immunotherapy
Speaker: Wang, Jiacheng - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
1:15 PM - 1:25 PM PT

325 - Universal Deep Learning Dose Prediction for IMRT Planning
Speaker: Wang, Qingying, MS - University of Texas Southwestern Medical Center, Dallas, TX
1:25 PM - 1:35 PM PT

304 - Genomic Mutation-Driven Stratification of Treatment Response to Stereotactic Spine Radiosurgery in Spinal Metastases
Speaker: Al-Sharfeen, Areeba, BS - MD Anderson Cancer Center, Houston, TX
1:25 PM - 1:35 PM PT

310 - A Phase II Study of Durvalumab and Tremelimumab with Radiation Therapy in Patients with Advanced Hepatocellular Carcinoma and Biliary Tract Cancer
Speaker: Koenig, Julie, MD - Mass General Brigham, Somerville, MA